Perspective

Split Viewer

Blood Res 2013; 48(1):

Published online March 31, 2013

https://doi.org/10.5045/br.2013.48.1.3

© The Korean Society of Hematology

Blood Research: a new journey of passion with harmony beyond Asia onto the world

Hong Hoe Koo, M.D. Ph.D.

Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

REFERENCES

  1. Kwon, SW. The KJH: Sailing over the horizon. Korean J Hematol, 2010;45;77-78.
    Pubmed
  2. Lee, JH, Joo, YD, Kim, H, et al. Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine. J Clin Oncol, 2013;31;701-709.
    Pubmed
  3. Kim, SJ, Kim, K, Kim, BS, et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study. J Clin Oncol, 2009;27;6027-6032.
    Pubmed
  4. Eom, HS, Kim, YK, Chung, JS, et al. Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP). Ann Hematol, 2010;89;489-497.
    Pubmed
  5. Yoo, KH, Lee, SH, Sung, KW, et al. Current status of pediatric umbilical cord blood transplantation in Korea: a multicenter retrospective analysis of 236 cases. Am J Hematol, 2011;86;12-17.
    Pubmed

Article

Perspective

Blood Res 2013; 48(1): 3-4

Published online March 31, 2013 https://doi.org/10.5045/br.2013.48.1.3

Copyright © The Korean Society of Hematology.

Blood Research: a new journey of passion with harmony beyond Asia onto the world

Hong Hoe Koo, M.D. Ph.D.

Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

    References

    1. Kwon, SW. The KJH: Sailing over the horizon. Korean J Hematol, 2010;45;77-78.
      Pubmed
    2. Lee, JH, Joo, YD, Kim, H, et al. Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine. J Clin Oncol, 2013;31;701-709.
      Pubmed
    3. Kim, SJ, Kim, K, Kim, BS, et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study. J Clin Oncol, 2009;27;6027-6032.
      Pubmed
    4. Eom, HS, Kim, YK, Chung, JS, et al. Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP). Ann Hematol, 2010;89;489-497.
      Pubmed
    5. Yoo, KH, Lee, SH, Sung, KW, et al. Current status of pediatric umbilical cord blood transplantation in Korea: a multicenter retrospective analysis of 236 cases. Am J Hematol, 2011;86;12-17.
      Pubmed
    Blood Res
    Volume 59 2024

    Stats or Metrics

    Share this article on

    • line

    Blood Research

    pISSN 2287-979X
    eISSN 2288-0011
    qr-code Download